NasdaqGM:NAMSBiotechs
NewAmsterdam Pharma (NasdaqGM:NAMS): Valuation in Focus After New Manufacturing Expansion with Piramal Pharma Solutions
If you’ve been eyeing NewAmsterdam Pharma (NasdaqGM:NAMS), the latest developments could make you pause and reassess next steps. This week, the company unveiled a dedicated oral solid dosage manufacturing suite in partnership with Piramal Pharma Solutions. This multi-million-dollar move is aimed at boosting production efficiency for its investigational fixed dose combination of obicetrapib and ezetimibe. The timing matters, as the facility is built to handle potential high demand if...